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ABSTRACT
Restriction endonuclease MvaI recognizes the
sequence CC/WGG (W stands for A or T, ‘/’
designates the cleavage site) and generates
products with single nucleotide 50-overhangs. The
enzyme has been noted for its tolerance towards
DNA modifications. Here, we report a biochemical
characterization and crystal structures of MvaI in an
apo-form and in a complex with target DNA at 1.5A ˚
resolution. Our results show that MvaI is a monomer
and recognizes its pseudosymmetric target
sequence asymmetrically. The enzyme consists of
two lobes. The catalytic lobe anchors the active
site residues Glu36, Asp50, Glu55 and Lys57 and
contacts the bases from the minor grove side. The
recognition lobe mediates all major grove inter-
actions with the bases. The enzyme in the crystal
is bound to the strand with T at the center of the
recognition sequence. The crystal structure with
calcium ions and DNA mimics the prereactive state.
MvaI shows structural similarities to BcnI, which
cleaves the related sequence CC/SGG and to MutH
enzyme, which is a component of the DNA repair
machinery, and nicks one DNA strand instead of
making a double-strand break.
INTRODUCTION
Restriction endonucleases (REases) are usually classiﬁed
according to their speciﬁcity, target site symmetry,
oligomeric structure and/or the presence of auxiliary
domains that modulate the activity (1). A less widely used
criterion for REase classiﬁcation is the length of sticky
ends in cleaved DNA duplexes. Grouping REases by
this criterion reveals a very uneven distribution in the
frequency of diﬀerent cleavage patterns. Indeed,
4 nucleotide (nt) 50-overhangs are most abundant.
Moreover, protruding 50-ends are more common than
recessed 50-ends and overhangs with an even number of
nucleotides outnumber those with an odd number (2). It is
currently thought that diﬀerent cleavage patterns are
mainly achieved by the changes at the dimer interface
between the conserved monomers of restriction enzymes
(3,4). However, the crystal structure of Ecl18kI,
which cleaves the CCNGG sequence and generates 5nt
50-overhangs demonstrated that Ecl18kI achieves its
speciﬁcity by a ﬂip of the central nucleotides rather than
by a rearrangement of the dimer interface (5). This ﬁnding
suggests that the cleavage pattern may reﬂect fundamental
structural diﬀerences and prompts further studies of
endonucleases that generate rare cleavage patterns.
Here, we focus on MvaI, the ﬁrst example of a restriction
enzyme that recognizes a pseudopalindromic sequence
CC/WGG (W stands for A or T) and generates 1nt
50-overhangs upon cleavage.
The MvaI REase is a part of the MvaI restriction–
modiﬁcation (RM) system discovered in Micrococcus
varians strain RFL19 (now renamed to Kocuria varians).
The MvaI REase is accompanied by the cognate
methyltransferase (MTase) which methylates the
N4-amino group of the inner cytosine residue making
the host DNA resistant to MvaI cleavage (6). The
modiﬁcation of the same cytosine to 5mC, which can be
catalyzed by several physiologically unrelated MTases,
is not protective against MvaI cleavage (7).
The MvaI REase is unusual in many respects. (a) The
enzyme generates 1nt 50-overhangs (6). (b) MvaI cleaves
unmodiﬁed DNA duplexes in two single-strand
scissions (8). (c) The cleavage rates of the two strands
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EcoRII REase, MvaI is very tolerant of modiﬁcations
in synthetic substrates (10). The enzyme completes the
cleavage of substrates with a nick in one strand,
irrespective of whether or not a phosphate is present at
the nicking site (8). Moreover, selective modiﬁcation
of one DNA strand typically aﬀects the cleavage of
either the modiﬁed or the unmodiﬁed strand, depending
on the nature of the modiﬁcation, but only very drastic
modiﬁcations impair cleavage of both strands (7,10).
Here, we show that MvaI is a monomer in solution
that binds duplex DNA in 1:1 stoichiometric ratio
and we present a crystallographic analysis of MvaI in
the apo- and DNA-bound forms both at 1.5A ˚ resolution.
The crystallographic results show that MvaI interacts with
a complete recognition site and not just with a half-site
of the pseudosymmetric target sequence. Therefore, we
suggest that the enzyme acts as a ‘nickase’ initially, but
may swing around its DNA target to make a second cut
that completes the cleavage reaction.
MATERIALS AND METHODS
MvaIREase cloning and expression
Escherichia coli strain ER2566 (F– –fhuA2 [lon] ompT
lacZ::T7 gene1gal sulA11  (mcrC-mrr)114::IS10R(mcr-
73::miniTn10–TetS)2R(zgb-210::Tn10)(TetS) endA1
[dcm]) was used as a host for cloning and overexpression
experiments. ER2566 strain was shown experimentally to
exhibit the dcm
  phenotype.
The MvaI REase (mvaIR) gene was ampliﬁed from the
cloning vector kindly provided by Fermentas (Vilnius,
Lithuania). The mvaIR gene was re-cloned into the
pBAD24 (Ap
r) vector and expressed in the ER2566
strain bearing plasmid pACYC184 (Cm
r) containing
pspGIM gene which was a gift from New England
Biolabs (USA). The expression vector for MvaI REase
encoded full-length MvaI with three additional MKS
amino acids at the N-terminus. To express MvaI REase
the ER2566 strain containing the pACYC184_M.PspGI
was transformed with pBAD24_R.MvaI. Cells were
grown in LB medium with appropriate antibiotics at
378Ct oO D 600 0.7 and MvaI REase expression induced
by addition of arabinose to the ﬁnal 0.2% concentration.
After 4h of induction the cells were harvested by
centrifugation and the pellet was stored at  208C.
MvaIpurification
Frozen cells were thawed and resuspended in 4 volumes of
buﬀer A (0.01M Tris-HCl, pH 8.0at 258C, 1mM EDTA,
7mM 2-mercaptoethanol) with 0.1M NaCl. The cell
suspension was sonicated and the cell debris was removed
by centrifugation at 18000 r.p.m for 1h. The supernatant
was loaded on phosphocellulose P11 column (Whatman)
equilibrated with buﬀer A with 0.1M NaCl. The MvaI
protein was not bound to P11 beads, the ﬂow-through was
collected and subjected to subsequent chromatography
on the Heparin Sepharose, Blue Sepharose (Amersham
Biosciences) and phosphocellulose P11 columns
(Whatman). The protein was eluted from all columns
with a linear NaCl gradient in buﬀer A. All puriﬁcation
steps were monitored by   DNA cleavage and
SDS-PAGE. Fractions containing MvaI REase activity
were pooled and dialyzed against storage buﬀer (0.01M
Tris-HCl, pH 8.0 at 258C, 0.4M KCl, 1mM EDTA,
1mM DTT, 50% glycerol) and stored at  208C.
The protein was puriﬁed to electrophoretic homogeneity
in a Coomassie-blue-stained SDS-gel. The overall yield of
MvaI puriﬁcation was 10mg from 5l culture.
Analytical ultracentrifugation
Analytical ultracentrifugation was done in an An-60 rotor
with a Coulter-Beckman Model XL-A analytical ultra-
centrifuge equipped with UV absorption detection using
charcoal ﬁlled epon centrepieces. Sedimentation velocity
was measured at 48C and 44000 r.p.m. in a buﬀer
containing 0.01M Tris-HCl, pH 7.4, 0.4M KCl, 0.1mM
DTT and 0.1mM EDTA at a loading concentration of
2.5mmol. Absorption proﬁles were recorded at 230nm to
increase the sensitivity of detection. The sedimentation
coeﬃcient distribution was analyzed with the program
SEDFIT (11). Viscosity and density correction to calculate
s208C,W was done using the data supplied by the program
package SEDNTERP (http://www.rasmb.bbri.org).
Sedimentation equilibrium was measured in six-channel
centrepieces at 18000 r.p.m. and 208C. Samples were spun
until no change in absorbance proﬁles could be observed
for at least 12h at which time equilibrium was assumed
to have been reached. Molar masses were evaluated from
the concentration gradients observed in these last 12h as
described earlier (12).
Analytical gel filtration
Here, 30mg (1nmol) of MvaI protein was mixed with
blunt-ended 9-mer cognate oligoduplex 1 (Figure 1A) in
buﬀer B (0.01M Tris-HCl, pH 8.0, 0.3M KCl, 5mM
CaCl2, 1mM DTT, 5% glycerol) at diﬀerent stoichio-
metric ratios, and incubated on ice for 1h. The samples
were loaded on a Superose
TM 12 HR 10/30 column
(Amersham Biosciences), which was equilibrated in buﬀer
B and run with a ﬂow rate of 0.4ml/min. The column was
calibrated with Biorad protein standards (vitamin B-12,
1.35kDa; myoglobin, 17kDa; ovalbumin, 44kDa; IgG,
150kDa and thyroglobin, 670kDa). For the interpolation
of unknown molecular mass, a linear dependence of the
logarithm of the molecular mass on the elution time was
assumed.
Elution proﬁles were monitored by an Ettan
(Amersham) two-wavelength detector at 260 and
280nm. The A(260):A(280) absorbance ratios necessary
for proﬁle deconvolution were deduced from the ratios
of A(260) and A(280) peak heights after injection of only
protein or only DNA. For our system, we determined
A(260):A(280)  1.9 for DNA and A(260):A(280)  0.56
for MvaI without DNA. Absolute absorbance values were
calculated as follows: for the double-stranded DNA,
an A(260)¼1cm
 1 was taken to correspond to 0.15mM
nucleotides or 8.33mM of the 9-mer oligoduplex.
For MvaI apo-form, an extinction coeﬃcient of
34380M
 1cm
 1 was calculated by the EXPASY server
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algebraic manipulations, it follows that cprotein¼
 21.3A(260)þ40.8A(280) and cDNA¼11.7A(260) 
6.5A(280), if absorbances and concentrations are
measured in units of cm
 1 and mM, respectively.
Native gel electrophoresis
Native gel electrophoresis was run in acidic conditions
according to a protocol from Dr Lebendiker (The
Hebrew University, Jerusalem, http://wolfson.huji.ac.il/
puriﬁcation/Protocols/PAGE_Acidic.html). Electrophor-
esis was performed at 48C at 25mA. Care was taken to
reverse the polarity relative to the usual arrangement,
because at pH 4.3 the proteins migrate as positively
charged species. Here, 5mg (0.17 nmol) of MvaI was mixed
in 10ml of buﬀer B with oligoduplex 1 (Figure 1A) in
various stoichiometric ratios. Mixtures were incubated on
ice overnight, supplemented with 2ml of loading
dye (1.45ml of 50% glycerol, 0.5ml of 0.25M acetate-
KOH, traces of methylene green) and immediately loaded
on the gel.
Crystallization
Crystallization was done by the vapor diﬀusion technique
at room temperature. Initial high-throughput screens were
set up at the 200-nl scale using a Cartesian pipetting robot
and 96-well Greiner sitting drop plates. Crystallization
trials with larger drop volumes were pipetted in
CRYSCHEM plates (Hampton Research).
DNA-free form. MvaI was dialyzed against buﬀer B and
concentrated to 7mg/ml. Initial screening identiﬁed
Hampton Research Crystal Screen 2 buﬀer 34 (0.05M
cadmium sulfate hydrate, 0.1M HEPES pH 7.5, 1.0M
sodium acetate trihydrate) as promising for crystalliza-
tion. The best crystals appeared in a drop containing 1.5ml
of protein, 1.5ml of buﬀer C (0.05M cadmium sulfate
hydrate, 0.1M HEPES pH 7.74, 1.2M sodium acetate
trihydrate) and 0.3ml of 1M glycine as an additive, which
was equilibrated against buﬀer C in the reservoir.
The largest crystal was ﬂash-cryocooled in a drop
containing 16ml buﬀer C, 2ml of 1M glycine and 2mlo f
(2R,3R)-( )-2,3-butandiol. Diﬀraction improved after
a single annealing step.
DNA-bound form MvaI was mixed with oligoduplex 2
(Figure 2). in 1:1 molar ratio and incubated overnight on
ice. The protein–DNA complex (ﬁnal concentration
6.4mg/ml) was applied on a 24-well plate with appropriate
buﬀers. The crystals appeared in a drop containing 2ml
of protein and DNA solution and 2ml of buﬀer D
(0.1M HEPES pH 7.89, 0.2M CaCl2, 25% PEG4000).
Crystals were ﬂash-cryocooled in crystallization buﬀer D
supplemented with 20% of glycerol.
Data collection and structure determination
All diﬀraction data were collected at 100K. In-house data
were measured on a RUH300 generator with copper
anode from MSC/Rigaku equipped with Osmic multilayer
optics and an MAR345 image plate. Synchrotron data
were collected at beamline BW6 at DESY, Hamburg.
All data were processed with MOSFLM (14) and scaled
with SCALA (15) (Table 1).
DNA-free form. This crystal form contained two MvaI
molecules in the asymmetric unit. It was solved by the
SAD method, taking advantage of the presence of Cd
2þ
ions in the crystallization buﬀer, which bound to some
deﬁned sites on the protein surface. Five Cd
2þ sites were
identiﬁed with reasonable statistics (CCall 28.7, CCweak
17.3) by the SHELXD program (16). Initial phasing with
these sites in SHELXE (17) resulted in a signiﬁcant
contrast diﬀerence (0.61 for the correct hand versus 0.45
for the incorrect hand assuming 50% solvent content).
Optimal SAD phases were calculated by the SHARP
program and then extended to the full resolution of the
synchrotron dataset. The extended phases were of
suﬃcient quality for ARP/wARP (18) to automatically
build 333 amino acids in 19 chains or 67% of the total
number of residues that are chemically present in the
MvaI crystals. The partial model was suﬃcient to derive
the non-crystallographic (NCS) symmetry, which could
then be used to map fragments between monomers. The
‘symmetrized’ model was then used as the starting point
for a further round of model building, and then polished
manually.
Figure 1. Analytical gel ﬁltration experiments to determine the MvaI oligomeric state and the stoichiometry of DNA binding for the oligoduplex 1
shown in (A). Elution proﬁles were recorded simultaneously at 260 and 280nm and deconvoluted to obtain separate curves for the MvaI (blue) and
DNA (red) concentration. (B) MvaI alone, (C) DNA alone, (D) mixture with a 2:1 molar excess of MvaI over DNA, (E) stoichiometric mixture,
(F) mixture with a 2:1 molar excess of DNA over MvaI, (G) calibration curve for Superose
TM 12 HR 10/30 column (Amersham Biosciences) with
standards from Biorad (vitamin B-12, 1.35kDa; myoglobin, 17kDa; ovalbumin, 44kDa; IgG, 150kDa and thyroglobin, 670kDa).
Nucleic Acids Research, 2007, Vol. 35, No. 6 2037DNA-bound form. This crystal form contained two
complexes of MvaI bound to duplex DNA in the
asymmetric unit. Molecular replacement was unsuccessful
with the complete MvaI model from the DNA-free crystal
form, but two copies of the recognition domain could
be placed using the MOLREP program. The initially
weak model phases were improved using the protocol for
NCS-phased reﬁnement from the CCP4i interface. The
resulting phases were of suﬃcient quality for automatic
model building using ARP/wARP (18). DNA was
built manually starting from a model of B-DNA of the
proper sequence generated with the modeling program
3DNA (19).
Manual corrections to the models were done with the
programs O (20) and XtalView (21). All structures were
reﬁned with the maximum likelihood program REFMAC
(22) treating each lobe of MvaI and each DNA duplex as
separate TLS entities. Data collection and reﬁnement
statistics are summarized in Table 1.
RESULTS
MvaI isamonomer according to analytical
ultracentrifugation
At the sequence level, MvaI shows weak similarities to the
monomeric DNA repair protein MutH (23). This result
prompted us to check the oligomerization state of MvaI
in solution. Analytical ultracentrifugation shows MvaI
to be mostly monomeric. Sedimentation velocity runs
Figure 2. Summary of MvaI–oligoduplex 2 interactions. Residues of the catalytic and recognition lobes are marked in orange and green, respectively.
Arginine, lysine and histidine residues of MvaI involved in the interactions with DNA phosphate oxygen atoms are indicated close to the respective
phosphates. Direct hydrogen bonding interactions of MvaI with the DNA bases are indicated next to the bases, on their right side (e.g. Y213 and
N45 interact with Tþ3). Indirect water-mediated hydrogen bonding interactions are not shown. The black arrows indicate the MvaI cleavage sites.
The binding mode of the DNA in the MvaI crystals brings only the T-strand close to the active site. Labels A, B, C, D, E and F refer to the panels in
Figure 5.
Table 1. Data collection, phasing and reﬁnement statistics
MvaI without DNA (20.0–1.5A ˚ ) MvaI with DNA (30.0–1.5A ˚ )
Space group P2(1) P2(1)
a( A ˚ ) 58.5 53.9
b( A ˚ ) 63.3 81.4
c( A ˚ ) 71.9 71.3
b (8) 100.8 90.5
Wavelength (A ˚ ) 1.54 (in house) 1.05 (BW6, DESY) 1.05 (BW6, DESY)
Resolution range (A ˚ ) 12.0–1.7 20.0–1.5 30.0–1.5
Total reﬂections 243586 233261 298191
Unique reﬂections 52083 75246 94979
Completeness (%) (last shell) 91.6 (99.0) 91.2 (99.6) 96.6 (95.3)
I/  (last shell) 10.8 (2.9) 30.8 (4.1) 6.2 (2.5)
R(sym) (%) (last shell) 5.2 (25.0) 6.1 (23.2) 7.0 (28.8)
B(iso) from Wilson (A ˚ 2) 17.3 19.8 14.5
FOM (SHARP) 0.375 – –
Reﬂections work/test 68906/3629 90188/4789
Protein atoms (excluding H) 3847 4081
DNA atoms (excluding H) – 868
Solvent molecules 313 583
R-factor (%) 18.4 17.7
R-free (%) 21.2 19.5
RMSD bond lengths (A ˚ ) 0.014 0.008
RMSD angles (8) 1.5 1.2
Ramachandran core region (%) 92.8 90.5
Ramachandran allowed region (%) 7.2 9.1
Ramachandran additionally allowed region (%) 0.0 0.0
Ramachandran disallowed region (%) 0.0 0.4
2038 Nucleic Acids Research, 2007, Vol. 35, No. 6in the analytical ultracentrifuge with MvaI gave a
sedimentation constant of s208C,W¼2.62S. Using a mass
for the monomeric protein of 28.6kg/mol this corresponds
to a frictional ratio of 1.27. For spherical hydrated
proteins, a frictional ratio of 1.1–1.2 is expected (24) and
thus MvaI can be viewed as a mostly globular, monomeric
particle. Sedimentation equilibrium gave a molar mass of
35kg/mol indicating the protein to show some aggrega-
tion. This aggregation could be suppressed by the addition
of 0.8M GuaHCl where a molar mass of 27.5kg/mol
is observed.
MvaI isamonomer according toanalytical gel filtration
The monomeric state of MvaI in the apo-form and in
complex with the cognate, blunt-ended 9-bp oligoduplex 1
(Figure 1A) was independently analyzed by analytical
gel ﬁltration. Experiments were run in the presence of
calcium ions, which support DNA binding, but
not hydrolysis (data not shown). Although MvaI and
MvaI–DNA complexes are not resolved on the column,
the amounts of MvaI and DNA in the elution peaks could
be separately quantiﬁed at 260 and 280nm, respectively,
and deconvoluted based on the known A(260):A(280)
absorbance ratios for MvaI and DNA (see Materials and
methods). For consistency, the deconvolution procedure
was applied to all proﬁles, even if only protein or only
DNA was injected (Figure 1B–F).
In the experimental conditions (see Materials and
methods), MvaI alone elutes from the column at 13.82ml,
which translates into a molecular mass of 30 3kDa, in
agreement with the calculated monomer mass 28.6kDa
(Figure 1B,G). The cognate 9-bp oligoduplex 1 (Figure 1A)
alone elutes much later, at 15.47ml (Figure 1C), but it
coelutes with MvaI up to a stoichiometric ratio of 1
oligoduplex per 1 MvaI monomer (Figure 1D and E). If
oligoduplex is present in excess over the MvaI monomer,
two peaks result. One equivalent of DNA coelutes with
the protein, and the rest elutes as free DNA (Figure 1F).
The retention volume for the MvaI–DNA complex is
14.01ml and corresponds to an apparent molecular mass
value of 26 2kDa (Figure 1G) which is slightly lower
than the apparent mass of MvaI alone, probably because
the more compact shape of the complex nearly balances
the increase in molecular mass due to DNA binding. We
conclude that MvaI remains monomeric in the presence of
cognate DNA, at least in our experimental conditions.
Our ﬁndings are inconsistent with a prior report of MvaI
dimerization in the presence of both cognate and non-
cognate DNA (25).
MvaI binds duplex DNA in 1:1stoichiometric ratio
The gel ﬁltration experiments suggest that MvaI is a
monomer that binds target duplex DNA in 1:1 stoichio-
metric ratio. This was independently conﬁrmed by gel
electrophoresis under acidic conditions (see, Materials and
methods). In these conditions, free DNA does not enter
the gel, but MvaI alone (predicted isoelectric point 6.8)
migrates into the gel (Supplementary Figure 1, lane 1).
The addition of substoichiometric amounts of cognate
oligoduplex leads to the appearance of a second, slower
migrating band, the MvaI–DNA complex (Supplementary
Figure 1, lane 2). If oligoduplex is added in stoichiometric
ratio, the band from MvaI alone almost disappears, and
essentially only the MvaI–DNA band is present
(Supplementary Figure 1, lane 3). Still further increase
of the DNA concentration has no eﬀect on the band
pattern (Supplementary Figure 1, lane 4).
MvaIstructure determination
The available biochemical data on MvaI and our ﬁndings
about its oligomeric state and DNA-binding stoichiome-
try suggested that MvaI is a highly unusual restriction
enzyme and prompted us to determine its structure. MvaI
was crystallized in the apo-form and in the presence of
oligoduplex 2 (Figure 2). The crystals with and without
DNA happened to be monoclinic and diﬀract to 1.5A ˚
resolution. The apo-form was solved by the SAD method,
and the form with DNA by molecular replacement, using
the previously determined model of the DNA-free form
(details in Materials and methods and Table 1).
Both crystal forms of MvaI contained two monomers in
the asymmetric unit. In the apo-structure, the interaction
of the monomers, which are related by a curious 2-fold
symmetry, buries  1800A ˚ 2 of solvent-exposed surface.
Despite this extensive contact, the interaction cannot be
physiological, because (a) it is not observed in solution, (b)
the interface is not conserved and (c) it locks MvaI in an
open conformation that is not compatible with DNA
binding (see below). In the crystals of the MvaI–DNA
complex, the largest interfaces between adjacent molecules
in the crystal bury only  900 and  600A ˚ 2. Moreover,
these contacts relate molecules that cannot be mapped
on each other by a simple 2-fold rotation, and they diﬀer
from the extensive contact in the apo-MvaI structure.
Therefore, we conclude that MvaI crystallized as
a monomer in all cases. The two molecules in the apo-
MvaI structure are very similar, probably because the
local 2-fold axis enforces it. Likewise, the two MvaI
molecules in the asymmetric unit of the crystals with DNA
overlap almost perfectly, probably because the complexes
with DNA are very compact and therefore rigid. The same
is true for the bound DNA duplexes, which can be
described by very similar conformational parameters
according to the 3DNA program (19) (Supplementary
Table 1), even though no restraints or constraints were
applied during reﬁnement. For simplicity, we will not
distinguish between the two monomers in each crystal
form in the following text.
MvaIconsists of two lobes
MvaI is organized into two lobes which we term the
catalytic lobe (residues 1–63, 160–188 and 238–246,
orange in Figure 3) and the recognition lobe (residues
64–159 and residues 189–237, green in Figure 3) based on
their mechanistic roles discussed below. The orientation
of the two lobes diﬀers radically depending on whether or
not DNA is bound: in the absence of DNA, the molecule
has an almost ﬂat appearance (Figure 3A), but in the
presence of DNA, it forms a tight ‘clamp’ around
it (Figure 3B). Despite the drastic change in hinge
Nucleic Acids Research, 2007, Vol. 35, No. 6 2039angle ( 548), there is no major conformational diﬀerence
within the lobes, except in loops (Figure 3C and D
and Supplementary Figure 2). The rearrangement of
residues 40–57 is signiﬁcant, because this region includes
catalytic residues.
Catalytic lobe
The catalytic lobe is organized around a four-stranded
mixed b-sheet which is ﬂanked by two a-helices and a
310-helix (orange part of Figure 4). The topology of the
sheet is þ1x, þ1, þ1, þ1 according to the Richardson
nomenclature (26). Note that elements of the recognition
lobe are interspersed between strands bC1 and bC2 and
also between strands bC3 and bC4. Strands bC2 and bC3
are connected by a simple hairpin. The fold of the catalytic
lobe is fairly similar to the fold of its counterpart in
MutH, which has been termed the ‘N-arm’ of this enzyme
(27). There are also other, more distant similarities to the
cores of other REases of the PD...EXK family (data not
shown).
The term ‘catalytic’ lobe was chosen because this part
of MvaI anchors all catalytic residues of the enzyme.
In addition, it also contributes some of the minor grove
interactions with DNA, which are unlikely to play a major
role in sequence discrimination (see below).
Recognition lobe
In contrast to the catalytic lobe, the recognition lobe is
characteristic of MvaI. The fold is organized around two
antiparallel b-sheets (green part of Figure 4). The larger
of the two sheets consists of strands bR1, bR2, bR3, bR7
and bR8/bR9, which are connected in þ4x,  1,  1,  1
topology. This would correspond to the Greek key motif if
the small bR2 is not taken into account. The smaller sheet
is built from strands bR4, bR5 and bR6 and is a b-
meander. Protein architecture dictates two preferred ways
for b-sheets to stack against each other: aligned, with an
angle between the strands in the two sheets  308, and
perpendicular, with an angle between the strands  908
(28,29). The MvaI recognition lobe clearly belongs to
the latter group and therefore resembles a half-barrel or
barrel (30,31) except for the lack of hydrogen bonds
to connect the sheets.
The term ‘recognition’ lobe was chosen because this
lobe anchors the residues that interact speciﬁcally with
the major grove of DNA and likely mediate sequence
discrimination. We also note that nearly all basic residues
(Lys64, Lys72, Arg85, Lys90, His100, Arg107, Lys159,
Lys205, His214) that interact with the phosphodiester
backbone of DNA are located in the recognition lobe.
One activesite, asymmetric recognition of the
pseudosymmetric targetsequence
MvaI acts as a monomer and recognizes its pseudosym-
metric target sequence asymmetrically (Figures 2 and 3B).
As the enzyme has only one active site, this implies that
only one strand can come into proximity of the active site.
Although MvaI can bind target DNA in two orientations,
the strand with the central T (‘T-strand’) binds exclusively
or predominantly close to the active site in our crystal
form of MvaI with DNA.
Sequence readout
As expected, MvaI contacts the speciﬁcally recognized
target bases, but in addition it also engages in hydrogen
bonds with a ﬂanking base pair. In all positions, the
catalytic lobe approaches the bases exclusively from
the minor grove side, and the recognition lobe interacts
with the bases exclusively from the major grove side.
For the detailed discussion, we follow the T-strand from
the  3 to the þ2 position (from left to right according to
the scheme in Figure 2).
A 3T þ3: This A-T base pair is not part of the
recognition sequence, but it nevertheless makes two direct
hydrogen bonds with MvaI. The O2 and O4 atoms of
thymine accept hydrogen bonds from the side chain
amide group of Asn45 and the OH of Tyr213, respectively.
From the structural perspective, it can be expected that
these interactions contribute little to sequence speciﬁcity:
the position of the O2 atom, the so-called ‘outer minor
grove’ is taken by a hydrogen bond acceptor for all four
possible base pairs (32). On the major grove side, the side
chain oxygen atom of Tyr213 can act as a hydrogen bond
donor as in the crystallographically observed complex,
but might also act as a hydrogen bond acceptor, if other
base pairs are present in this position (Figure 5A).
C 2G þ2: This C-G base pair forms only indirect
hydrogen bonds with MvaI on the minor grove side, but
is involved in two direct hydrogen-bonding interactions
Figure 3. Overall view of the MvaI structure. The catalytic lobe of
MvaI is shown in orange and the recognition lobe is presented in green.
(A) Ribbon representation of the open conformation in the apo-form of
MvaI. Rotation of the recognition lobe around the blue axis by 548
brings this lobe into a similar orientation relative to the catalytic lobe
as in the MvaI–DNA complex. (B) Ribbon representation of the closed
conformation in the MvaI–DNA complex. The DNA strand that comes
close to the active site and would be cleaved in the presence of Mg
2þ
ions is shown in dark red. The complementary strand is presented
in black. (C) Superposition of the Ca-traces of the catalytic lobes
taken from the structures without (orange) and with (gray) DNA.
(D) Superposition of the Ca-traces of the recognition lobes from the
structures without (green) and with (gray) DNA. All panels were
prepared with the MOLSCRIPT program (44).
2040 Nucleic Acids Research, 2007, Vol. 35, No. 6with the enzyme on the major grove side. The N4 atom of
cytosine donates a hydrogen bond to the main chain
carbonyl oxygen atom of Asp224 and the O6 atom of
guanine accepts a hydrogen bond from the N" atom
of His223. This interpretation requires that His223 is
either charged or is in the tautomeric state with the proton
on the N" atom (Figure 5B and data not shown).
C 1G þ1: This C-G base pair makes an indirect
hydrogen bond to Arg25 on the minor grove side and
interacts with His225 on the major grove side. The main
chain carbonyl oxygen atom of this residue accepts a
hydrogen bond from the N4 atom of cytosine, and the Nd
atom of its imidazole ring donates a hydrogen bond to the
O6 atom of guanine. For the interaction between the
Figure 4. Schematic representation of the MvaI fold. The catalytic domain is in orange and the recognition domain is in green. Catalytic residues are
marked by black dots, and residues that are involved in hydrogen-bonding interactions are marked by colored circles. Colors are ramped from red to
blue following the T-strand in 50 !30 direction. Filled circles mark residues that interact with the T-strand and open circles indicate residues that
interact with the A-strand in the crystal structure. The secondary structure assignment was done for the structure with DNA using the DSSP
program (45): aC1 (L5-V16), aC2 (G30-L38), bC1 (I54-E60), 310C (T61-A63), bR1 (L67-T71), aR1 (A80-Y88), bR2 (K90-K91), bR3 (N97-V103),
bR4 (Y116-D123), bR5 (V128-D135), bR6 (M140-S148), aR2 (F149-K159), bC2 (Y162-E173), bC3 (K176-T188), aR3 (V192-N201), bR7 (I204-A212),
bR8 (T222-D224), bR9 (A228-I231), 310R (M233-E238) and bC4 (E241-V244).
Figure 5. Hydrogen-bonding interactions between MvaI and DNA. Panels are ordered following the T-strand in 50 !30 direction as indicated in
Figure 2. Residues of the catalytic lobe are labeled in orange, and residues of the recognition lobe are in green. Hydrogen bonds are indicated by
dotted lines. Prior experimental results on the eﬀects of single-strand methylations are indicated below the interaction diagrams. A ‘þ’ sign indicates
that the methylation is compatible with T-strand cleavage, and a ‘ ’ indicates that the corresponding methylation reduces T-strand cleavage by at
least 50%. The abbreviations (a), (b), (c), (d) refer to the following publications. (a) Gromova et al. (1991) (10) (b) Butkus et al. (1985) (6)
(c) Kubareva et al. (1988) (7) (d) Kubareva et al. (1990) (46).
Nucleic Acids Research, 2007, Vol. 35, No. 6 2041imidazole ring and the base to be sequence selective, the
tautomerization state of His225 should be locked by
interactions within MvaI, and not just by the hydrogen
bond to the base. As the N" atom of His225 interacts
with a water molecule that could be either a donor or an
acceptor, if and how this ‘lock’ is provided remains
unclear (Figure 5C and data not shown).
T0 A0: This T-A base pair accepts a direct hydrogen
bond from Thr29 Og to the thymine O2 atom and an
indirect hydrogen bond to the adenine N3 atom. As the
‘outer minor grove’ positions are taken by hydrogen bond
acceptors for all possible base pairs, this interaction
probably contributes little to speciﬁcity. On the major
grove side, Arg209 donates a hydrogen bond to the O4
oxygen atom of the T-strand thymine in the crystallized
MvaI–DNA complex. There is no trace of the alternative
binding mode, which swaps purine and pyrimidine and
must occur as well in solution (Figure 5D).
Gþ1C 1: This G-C base pair is involved in extensive
hydrogen-bonding interactions. On the minor grove side,
Asn28 accepts a direct hydrogen bond from the N2 atom
of guanine and anchors a water molecule that donates
a hydrogen bond to the O2 atom of cytosine. On the major
grove side, the carboxylate of Asp207 accepts a direct and
a water-mediated hydrogen bond from the cytosine N4
atom. The guanidino group of Arg209 and Thr68 Og
atoms donate hydrogen bonds to the O6 and N7 atoms of
guanine, respectively (Figure 5E).
Gþ2C  2: This G-C base pair makes only major
grove interactions with MvaI. The guanidino group of
Arg230 donates hydrogen bonds to the guanine atoms O6
and N7, and the Thr102 Og atom accepts a hydrogen
bond from the cytosine N4 atom (Figure 5F).
Methylation sensitivity
The methylation sensitivity of MvaI has been extensively
studied with special emphasis on the diﬀerential eﬀects
of methylation on the hydrolysis of the two DNA strands.
Experimentally, it was found that 5mC can replace
cytosine in all positions (Supplementary Table 2), but
this would have been diﬃcult to predict from the
crystallographic results. In silico introduction of 5mC
instead of the outer and inner cytosines of the T-strand
brings the extra methyl groups within 2.9A ˚ of Gly226Ca
and within 3.0A ˚ of His225 O, respectively, if base
positions are not adjusted and the enzyme is kept rigid.
Similarly, in silico conversion of the cytosines to 5mC in
the A-strand would introduce methyl groups 2.3A ˚ away
from Thr102 Og and 3.3A ˚ away from His100Cb,
respectively, and would additionally require the displace-
ment of a water molecule. Therefore, the experimentally
observed tolerance of MvaI to 5mC has to be attributed
either to ﬂexibility of the enzyme, or alternatively to
the adjustability of the exact positions of the bases
(data not shown).
In contrast to the eﬀects of C5 methylation, the
consequences of N4 methylation on T-strand cleavage
can be readily explained by the crystal structure. N4mC
cannot replace the inner cytosine in either strand, because
the extra methyl group would clash with a hydrogen
bond acceptor of the protein (His225 O, Figure 5C and
Asp207 Od, Figure 5E). Likewise, N4mC in the outer
position of the T-strand is not tolerated, again because the
methyl group would clash with a hydrogen bond acceptor
on the protein (Asp224 O in this case, Figure 5B).
Experimentally, substitution of the A-strand outer cyto-
sine with N4mC has been reported not to interfere with
cleavage: apparently the methyl group can displace the
side chain of Thr102 (Figure 5F).
Substitution of the central adenine with N6mA inter-
feres with A-strand cleavage, but does not aﬀect T-strand
cleavage. The latter result is consistent with the crystal
structure, because the methyl group of N6mA only needs
to displace a water molecule to ﬁt in (Figure 5D).
The rules for T-strand cleavage have direct implications
for A-strand cleavage, and therefore the above results
can be summarized in four simple rules: (a) substitution
of cytosine with 5mC has no eﬀect. (b) Substitution of
the inner cytosine with N4mC in one strand blocks
cleavage of both strands. (c) Substitution of an outer
cytosine in one strand by N4mC abolishes cleavage of
this strand, but does not interfere with cleavage of the
complementary strand. (d) Substitution of the central
adenine with N6mA aﬀects A-strand, but not T-strand
cleavage. Together, these four rules correctly predict the
outcome of a large number of experiments on the
methylation sensitivity of MvaI (Supplementary Table 2).
Note that the MvaI MTase methylates the N4 atoms of
the inner cytosines. Rule (b) predicts correctly that this
modiﬁcation interferes with DNA cleavage. Conversely,
the Dcm MTase converts the same cytosine to 5mC,
which should not have an eﬀect on DNA cleavage.
This is consistent with the experimental observation that
DNA from dcmþ strains can be cleaved by MvaI
(Supplementary Table 2).
MvaI active site
MvaI crystals with and without DNA were grown in the
absence of Mg
2þ, but in the presence of Ca
2þ ions, which
support DNA binding (see Figure 1), but not DNA
hydrolysis (data not shown). In the DNA-free form, Cd
2þ
ions were present in addition to the Ca
2þ ions, but no
metal ions were found in the vicinity of the active site
residues. This unexpected result is due to the arrangement
of residues 40–57, which are present in radically diﬀerent
conformations in the apo-MvaI structure (Figure 6A) and
in the complex with DNA (Figure 6B).
In the productive orientation two metal-binding sites
are formed, which are occupied by Ca
2þ ions from the
buﬀer (the identiﬁcation of the metals is supported by
the ligand distances and the X-ray anomalous signal).
In both standard electron density maps and anomalous
diﬀerence Fourier maps, the peak heights for the two
metals are very diﬀerent. The weaker peak (yellow ball in
Figure 6C) corresponds to a Ca
2þ liganded to an oxygen
atom of the scissile phosphate, one Asp50 Od atom
and three or four water molecules (depending on which
molecule in the asymmetric unit is used for the analysis).
The stronger peak corresponds to a hexa-coordinated
Ca
2þ ion with an almost perfect octahedral
2042 Nucleic Acids Research, 2007, Vol. 35, No. 6coordination sphere. The ligands to this metal ion are the
other Od oxygen atom of Asp50, the O" atom of Glu55,
the main chain carbonyl oxygen atom of Ile56, an oxygen
atom of the scissile phosphate, which acts as a bridge
between the two metals, and two solvent molecules
(Figure 6C).
One of these solvent molecules, which could either be
a water molecule or a hydroxide ion (shown with its
electron density in Figure 6C) is positioned exactly on
the line that links the O30 oxygen atom of the C 1 residue
to the phosphorus atom of the scissile phosphate.
This solvent molecule is ideally positioned for an in-line
attack on the phosphate atom, which might proceed via
a bipyramidal transition state and would correctly predict
reaction products with a free 30-end and a phosphorylated
50-end.
Although the above catalytic mechanism appears
plausible, the reaction does not proceed in the crystals,
as evidenced by several detailed features of the crystal
structure. (a) There is robust electron density for the
potentially scissile phosphorus oxygen bond, suggesting
that this bond is predominantly not cleaved. (b) At least at
the present resolution, there is no signiﬁcant deformation
of the tetrahedral geometry at the phosphorus atom
towards a trigonal bipyramidal arrangement. (c) The
putative ‘catalytic’ water molecule is 3.3A ˚ away from
the phosphorus atom. This distance is not signiﬁcantly
smaller than the sum of the van der Waals radii, if
coordinate errors of the crystal structure are taken into
account, but it is signiﬁcantly larger than a typical
phosphorus oxygen bond in DNA ( 1.6A ˚ ). Therefore,
it seems that the reaction has either not started in the
crystal structure, or alternatively that it is trapped very
early in the trajectory, which is consistent with the
biochemical observation that Ca
2þ ions in the active site
support DNA binding, but not DNA cleavage. Why is the
reaction blocked with Ca
2þ ions in the active site and
would proceed with Mg
2þ ions in the active site? Typical
oxygen ligand distances are much shorter for Mg
2þ than
for Ca
2þ (2.1A ˚ versus 2.4A ˚ ) (33), which might lead to a
slight mispositioning of the nucleophilic water molecule
in the complex with Ca
2þ. However, more sophisticated
simulation studies attribute the diﬀerent eﬃciencies of the
Mg
2þ and Ca
2þ forms of REases to kinetic eﬀects and




Nearly all restriction enzymes that recognize palindromic
or pseudopalindromic sequences form functional dimers
or higher order assemblies of dimers that match the 2-fold
symmetry or pseudosymmetry of their target sequence
(35). Nevertheless, our suggestion that MvaI interacts with
its (pseudo)palindromic target sequence as a monomer
already has precedence among REases. MspI and HinP1I,
which are speciﬁc for the palindromic sequences C/CGG
and G/CGC, respectively, have both been reported to be
monomers in solution (36–38).
In the case of MspI, the authors of the crystal structure
have proposed several possible explanations for how a
monomeric restriction enzyme can generate double-strand
breaks in DNA. (a) Although monomers are present in the
absence of DNA, there might be a monomer–dimer
equilibrium in the presence of DNA. Therefore, an initial
monomer–DNA complex might recruit another monomer
for the cleavage reaction. (b) Alternatively, MspI might
achieve double-strand DNA cleavage by bringing together
two monomers bound on two separate recognition sites.
(c) MspI might cut strands sequentially, possibly in
a concerted manner by a ﬂip of the enzyme around the
DNA after the ﬁrst cleavage reaction (36).
In the case of HinP1I, a conserved dimer is present in
crystals of the apo-form and of the DNA complex, despite
the predominantly monomeric nature of the enzyme in
solution (37). This unusual back-to-back dimer can bind
two copies of DNA, which are recognized asymmetrically
and are in contact with one active site (38). As expected,
only one strand was cleaved if these crystals were soaked
with Mg
2þ ions. In solution, HinP1I treatment of circular
DNA with multiple recognition sites leads ﬁrst to a nicked
product, but linear DNA appears earlier than one might
expect from a completely random nicking reaction,
suggesting either that the likelihood of strand hydrolysis
at any HinP1I site increases when the other strand
Figure 6. MvaI active site: (A) Conformation in the crystal of the apo-form. (B) Conformation in the cocrystals with DNA and Ca
2þ ions. In (B), the
yellow and orange balls represent the two Ca
2þ ions in the structure, and the dark red curve is the T-strand of DNA in ribbon representation.
(C) Stereo representation of the active site of MvaI in the form with bound DNA. The 2fofc density has been contoured at 1.2  and is shown around
the DNA and the catalytic water molecule or hydroxide ion. A productive nucleophilic attack, which does not take place in the crystals would
require an approach of the catalytic water molecule or hydroxide ion towards the phosphorus atom of the scissile phosphate along the green line.
Glu36at the back of the ﬁgure has not been labeled to avoid overlap.
Nucleic Acids Research, 2007, Vol. 35, No. 6 2043is cleaved or that the enzyme remains in the vicinity of its
site after hydrolysis and can rebind (38).
MvaIbinds pseudosymmetric DNA asymmetrically
The results reported here show that MvaI is a monomer
that recognizes its target DNA asymmetrically. The data
explain the cleavage rate diﬀerences for the two DNA
strands (8,9) and are consistent with a possible sequential
cleavage model. As MvaI forms a ‘clamp’ around the
DNA, rotation of MvaI around the long axis of DNA
seems plausible (Figure 3B). However, such a rotation
alone can never lead to a second productive binding event,
simply because the two DNA strands run in opposite
direction. To enable cleavage of the second strand by the
same active site, a rotation around the 2-fold axis of
pseudosymmetry perpendicular to the DNA is required to
position the enzyme in a second catalytically productive
orientation. The crystallographically observed hinge
mobility might be important to straighten out the protein
clamp, so that this rotation can proceed without clashes
with the DNA. However, alternative models to explain the
endonuclease activity of MvaI such as hairpin formation
(39,40) cannot yet be ruled out.
Our biochemical and crystallographic results indicate
that MvaI is monomeric in the presence and absence of
DNA and conﬂict with a prior report that MvaI dimerizes
in the presence of DNA (25). The crystal structure of the
MvaI-DNA complex shows that two monomers of MvaI
cannot simultaneously interact speciﬁcally with the target
DNA, because they would compete for interactions with
the same bases. Moreover, two MvaI monomers which
would be related by the (pseudo) 2-fold symmetry of the
target sequence would also clash in various other places
(not shown). Nonetheless, if MvaI dimerization on the
DNA is indeed relevant in some conditions, then hinge
mobility of MvaI could explain how one MvaI monomer
could recruit another monomer in a second productive




To our knowledge, MvaI is the ﬁrst crystallographically
studied REase that generates products with single
nucleotide 50-overhangs. The overhangs are 1nt shorter
than the 2nt overhangs generated by MspI and HinP1I.
This emphasizes the versatility of monomeric REases
with respect to the cleavage pattern. In principle, such
monomeric REases could generate overhangs of any
length, simply by asymmetrically binding a palindromic
or pseudopalindromic recognition sequence with the
center of symmetry or pseudosymmetry placed in the
appropriate distance from the scissile phosphate bond.
Note that although DNA recognition is asymmetric, the
target sequence has to be symmetric or pseudosymmetric,
simply because for double-strand breaks to occur, the
DNA must be recognized in both orientations by
the enzyme. The requirement for symmetry or pseudo-
symmetry of the target might be relaxed in cases with
degenerate sequence recognition.
MvaIisbarelysimilartotheneoschizomersEcoRIIandPspGI
MvaI recognizes the same sequence as EcoRII, but
generates single nucleotide 50-protruding ends while
EcoRII and PspGI produce ﬁve nucleotide 50-overhangs.
A comparison of the MvaI and EcoRII (41) protomers
shows that these two enzymes are barely related
[the DALI score 0.9 for the pairwise superposition is
insigniﬁcant (42)] The similarity is restricted to the
catalytic core, which is essentially conserved in all
restriction enzymes. Moreover, PspGI and EcoRII are
dimers and show similarities to the Ecl18kI enzyme
speciﬁc for the/CCNGG sequence (5) rather than MvaI.
This example indicates once more that cleavage stagger
and not only the target sequence should be considered as
the ‘phenotype’ of a restriction enzyme for the statement
‘phenotype predicts genotype’ (3) to hold true.
The catalytic domain ofMvaI issimilar to thecatalytic
domain ofthe DNA repair protein MutH
Weak sequence similarity at the PSI-BLAST level, which
has been noted before (23), suggests that MvaI is related
to MutH, a component of the DNA-repair machinery in
bacteria, which acts as a nickase on hemi-methylated
DNA (43). Despite the functional diﬀerences, there are
many parallels between MvaI and MutH. Both proteins
are two-lobed monomers and recognize almost symmetric
target sequences asymmetrically. A comparison of the
X-ray structures conﬁrms the similarities, particularly in
the vicinity of the active sites, but also reveals substantial
diﬀerences in the recognition domains, which is not
surprising because the two enzymes recognize unrelated
target sequences (CC/WGG for MvaI versus/GATC for
MutH). At the sequence level, MvaI is strikingly similar
to BcnI, which recognizes the related sequence CC/SGG
(S stands for C or G) and cleaves it like MvaI. In
accompanying manuscripts, we present the crystal struc-
tures of BcnI with and without target DNA and compare
them in detail with the corresponding structures for MvaI
and MutH.
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